` MAGLE (Magle Chemoswed Holding AB) vs OMX Stockholm 30 Comparison - Alpha Spread

M
MAGLE
vs
O
OMX Stockholm 30

Over the past 12 months, MAGLE has underperformed OMX Stockholm 30, delivering a return of -55% compared to the OMX Stockholm 30's +11% growth.

Stocks Performance
MAGLE vs OMX Stockholm 30

Loading
MAGLE
OMX Stockholm 30
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
MAGLE vs OMX Stockholm 30

Performance Gap Between MAGLE and OMXS30
HIDDEN
Show

Performance By Year
MAGLE vs OMX Stockholm 30

Loading
MAGLE
OMX Stockholm 30
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Magle Chemoswed Holding AB vs Peers

OMX Stockholm 30
MAGLE
0KHE
TMO
DHR
LONN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Magle Chemoswed Holding AB
Glance View

Magle Chemoswed Holding AB engages in the provision of contract development and manufacturing services to the pharmaceutical and medical device industry. The company is headquartered in Malmo, Skane. The company went IPO on 2020-06-30. The firm's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.

MAGLE Intrinsic Value
HIDDEN
Show
Back to Top